TNSN99124A1 - Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique et procede pour leur preparation. - Google Patents

Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique et procede pour leur preparation.

Info

Publication number: TNSN99124A1
Authority: TN; Tunisia
Prior art keywords: preparation; treatment; pharmaceutical compositions; musculoskletal; weakness
Prior art date: 1998-06-16

Application number

TNTNSN99124A

Other languages

English (en)

French (fr)

Inventor

Zhu Ke Hua

Li Mei

Codetta Pan Lydia

Duane Thompson David

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

1999-06-16

Publication date

2005-11-10

1999-06-16 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2005-11-10 Publication of TNSN99124A1 publication Critical patent/TNSN99124A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TNTNSN99124A 1998-06-16 1999-06-16 Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique et procede pour leur preparation. TNSN99124A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8946998P	1998-06-16	1998-06-16

Publications (1)

Publication Number	Publication Date
TNSN99124A1 true TNSN99124A1 (fr)	2005-11-10

Family

ID=22217825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNTNSN99124A TNSN99124A1 (fr)	1998-06-16	1999-06-16	Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique et procede pour leur preparation.

Country Status (30)

Country	Link
EP (1)	EP1087764A1 (zh)
JP (1)	JP2002518326A (zh)
KR (1)	KR20010052852A (zh)
CN (1)	CN1301160A (zh)
AP (1)	AP9901582A0 (zh)
AR (1)	AR018869A1 (zh)
AU (1)	AU4054799A (zh)
BG (1)	BG105041A (zh)
BR (1)	BR9911324A (zh)
CA (1)	CA2335134A1 (zh)
CO (1)	CO5070587A1 (zh)
EA (1)	EA200001186A1 (zh)
GT (1)	GT199900087A (zh)
HN (1)	HN1999000097A (zh)
HR (1)	HRP20000859A2 (zh)
HU (1)	HUP0102505A3 (zh)
ID (1)	ID27599A (zh)
IL (1)	IL138630A0 (zh)
IS (1)	IS5691A (zh)
MA (1)	MA26652A1 (zh)
NO (1)	NO20006312D0 (zh)
OA (1)	OA11505A (zh)
PA (1)	PA8475901A1 (zh)
PE (1)	PE20000646A1 (zh)
PL (1)	PL344981A1 (zh)
SK (1)	SK18912000A3 (zh)
TN (1)	TNSN99124A1 (zh)
TR (1)	TR200003544T2 (zh)
WO (1)	WO1999065486A1 (zh)
ZA (1)	ZA993975B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2360103A1 (en) *	1999-02-08	2000-08-17	Robert Sladek	Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
DE60124616T2 (de)	2000-05-08	2007-09-13	Pfizer Products Inc., Groton	Enzymatische Spaltung von selektiven Modulatoren des Östrogenrezeptors
CA2420535A1 (en) *	2000-08-30	2002-03-07	Mary Tanya Am Ende	Sustained release formulations for growth hormone secretagogues
IL145106A0 (en) *	2000-08-30	2002-06-30	Pfizer Prod Inc	Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) *	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) *	2004-08-31	2006-03-09	Pfizer Products Inc.	Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
ES2602789T3 (es)	2007-02-09	2017-02-22	Ocera Therapeutics, Inc.	Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA51676C2 (uk) *	1995-11-02	2002-12-16	Пфайзер Інк.	(-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis

1999
- 1999-06-15 PE PE1999000528A patent/PE20000646A1/es not_active Application Discontinuation
- 1999-06-15 AP APAP/P/1999/001582A patent/AP9901582A0/en unknown
- 1999-06-15 HN HN1999000097A patent/HN1999000097A/es unknown
- 1999-06-15 PA PA19998475901A patent/PA8475901A1/es unknown
- 1999-06-15 AR ARP990102848A patent/AR018869A1/es not_active Application Discontinuation
- 1999-06-15 ZA ZA9903975A patent/ZA993975B/xx unknown
- 1999-06-16 TN TNTNSN99124A patent/TNSN99124A1/fr unknown
- 1999-06-16 EA EA200001186A patent/EA200001186A1/ru unknown
- 1999-06-16 CA CA002335134A patent/CA2335134A1/en not_active Abandoned
- 1999-06-16 BR BR9911324-4A patent/BR9911324A/pt not_active Application Discontinuation
- 1999-06-16 CO CO99037622A patent/CO5070587A1/es unknown
- 1999-06-16 MA MA25628A patent/MA26652A1/fr unknown
- 1999-06-16 KR KR1020007014186A patent/KR20010052852A/ko not_active Application Discontinuation
- 1999-06-16 IL IL13863099A patent/IL138630A0/xx unknown
- 1999-06-16 TR TR2000/03544T patent/TR200003544T2/xx unknown
- 1999-06-16 JP JP2000554366A patent/JP2002518326A/ja active Pending
- 1999-06-16 EP EP99923802A patent/EP1087764A1/en not_active Withdrawn
- 1999-06-16 ID IDW20002627A patent/ID27599A/id unknown
- 1999-06-16 SK SK1891-2000A patent/SK18912000A3/sk unknown
- 1999-06-16 GT GT199900087A patent/GT199900087A/es unknown
- 1999-06-16 AU AU40547/99A patent/AU4054799A/en not_active Abandoned
- 1999-06-16 WO PCT/IB1999/001117 patent/WO1999065486A1/en not_active Application Discontinuation
- 1999-06-16 CN CN99806237A patent/CN1301160A/zh active Pending
- 1999-06-16 HU HU0102505A patent/HUP0102505A3/hu unknown
- 1999-06-16 PL PL99344981A patent/PL344981A1/xx not_active Application Discontinuation
2000
- 2000-10-20 OA OA1200000290A patent/OA11505A/en unknown
- 2000-10-27 IS IS5691A patent/IS5691A/is unknown
- 2000-12-11 BG BG105041A patent/BG105041A/xx unknown
- 2000-12-12 NO NO20006312A patent/NO20006312D0/no not_active Application Discontinuation
- 2000-12-14 HR HR20000859A patent/HRP20000859A2/hr not_active Application Discontinuation

Also Published As

Publication number	Publication date
HN1999000097A (es)	1999-11-03
ID27599A (id)	2001-04-12
CN1301160A (zh)	2001-06-27
EP1087764A1 (en)	2001-04-04
PE20000646A1 (es)	2000-08-05
HUP0102505A3 (en)	2002-12-28
KR20010052852A (ko)	2001-06-25
ZA993975B (en)	2000-12-15
AP9901582A0 (en)	1999-06-30
HRP20000859A2 (en)	2001-04-30
MA26652A1 (fr)	2004-12-20
NO20006312L (no)	2000-12-12
OA11505A (en)	2004-05-07
JP2002518326A (ja)	2002-06-25
AU4054799A (en)	2000-01-05
PA8475901A1 (es)	2000-05-24
PL344981A1 (en)	2001-11-19
IS5691A (is)	2000-10-27
TR200003544T2 (tr)	2001-04-20
HUP0102505A2 (hu)	2001-11-28
IL138630A0 (en)	2001-10-31
EA200001186A1 (ru)	2001-06-25
SK18912000A3 (sk)	2001-10-08
AR018869A1 (es)	2001-12-12
GT199900087A (es)	2000-12-07
BR9911324A (pt)	2001-04-03
NO20006312D0 (no)	2000-12-12
CA2335134A1 (en)	1999-12-23
CO5070587A1 (es)	2001-08-28
WO1999065486A1 (en)	1999-12-23
BG105041A (en)	2001-08-31

Similar Documents

Publication	Publication Date	Title
TNSN99125A1 (fr)	2005-11-10	Pyrrolo(2,3-d) pyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99126A1 (fr)	2005-11-10	Pyrrolopyrimidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99073A1 (fr)	2005-11-10	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98111A1 (fr)	2005-03-15	Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
TNSN99129A1 (fr)	2005-11-10	Formulations intranasales de mesylate de sildenafil et procede pour leur preparation
TNSN97192A1 (fr)	2005-03-15	Derives de pyrimidine bicycliques condenses, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98216A1 (fr)	2005-03-15	Derives d'acide hydrauxamique, compositions pharmaceutiques les contenant et procede pour leur preparation
TNSN98019A1 (fr)	2005-03-15	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
NO995006D0 (no)	1999-10-14	Nye forbindelser
TNSN99155A1 (fr)	2005-11-10	1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99171A1 (fr)	2005-11-10	4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98017A1 (fr)	2005-03-15	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98022A1 (fr)	2005-03-15	DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
TNSN99110A1 (fr)	2005-11-10	Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97078A1 (fr)	2005-03-15	Derives d'indole nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant
TNSN00121A1 (fr)	2005-11-10	Composes nouveaux inhibiteurs de metalloproteases, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98066A1 (fr)	2005-03-15	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN97122A1 (fr)	2005-03-15	Inhibiteurs des metalloproteinases de matrice a base de phosphinates
TNSN97144A1 (fr)	2005-03-15	Derives 6,6-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99106A1 (fr)	2005-11-10	Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26420A1 (fr)	2004-12-20	Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
TNSN00093A1 (fr)	2005-11-10	Modulateurs nouveaux des recepteurs de glucocorticoides, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98154A1 (fr)	2005-03-15	Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN99147A1 (fr)	2005-11-10	Procede d'emulsification
TNSN98024A1 (fr)	2005-03-15	2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.